{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T11:43:27Z","timestamp":1769600607893,"version":"3.49.0"},"reference-count":58,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Hematology"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1053\/j.seminhematol.2010.11.006","type":"journal-article","created":{"date-parts":[[2011,1,12]],"date-time":"2011-01-12T05:43:28Z","timestamp":1294811008000},"page":"22-31","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Molecular Imaging in Myeloma Precursor Disease"],"prefix":"10.1053","volume":"48","author":[{"given":"Esther","family":"Mena","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Choyke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esther","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ola","family":"Landgren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Kurdziel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.seminhematol.2010.11.006_bib1","doi-asserted-by":"crossref","first-page":"5412","DOI":"10.1182\/blood-2008-12-194241","article-title":"Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study","volume":"113","author":"Landgren","year":"2009","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2010.11.006_bib2","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/leu.2010.60","article-title":"Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management","volume":"24","author":"Kyle","year":"2010","journal-title":"Leukemia"},{"key":"10.1053\/j.seminhematol.2010.11.006_bib3","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1056\/NEJMra041875","article-title":"Multiple myeloma","volume":"351","author":"Kyle","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminhematol.2010.11.006_bib4","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.4065\/80.10.1371","article-title":"Multiple myeloma: diagnosis and treatment","volume":"80","author":"Rajkumar","year":"2005","journal-title":"Mayo Clin Proc"},{"key":"10.1053\/j.seminhematol.2010.11.006_bib5","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/1097-0142(197509)36:3<842::AID-CNCR2820360303>3.0.CO;2-U","article-title":"A clinical staging system for multiple myeloma","volume":"36","author":"Durie","year":"1975","journal-title":"Cancer"},{"key":"10.1053\/j.seminhematol.2010.11.006_bib6","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1016\/j.ejca.2005.11.037","article-title":"The role of anatomic and functional staging in myeloma: description of Durie\/Salmon plus staging system","volume":"42","author":"Durie","year":"2006","journal-title":"Eur J Cancer"},{"key":"10.1053\/j.seminhematol.2010.11.006_bib7","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1046\/j.1365-2141.1997.1122939.x","article-title":"Prognostic features of asymptomatic multiple myeloma","volume":"97","author":"Weber","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2010.11.006_bib8","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s11864-006-0016-7","article-title":"Smoldering multiple myeloma and monoclonal gammopathy of undetermined significance","volume":"7","author":"Blade","year":"2006","journal-title":"Curr Treat Options Oncol"},{"key":"10.1053\/j.seminhematol.2010.11.006_bib9","doi-asserted-by":"crossref","first-page":"3992","DOI":"10.1182\/blood-2006-05-026112","article-title":"Multiple myeloma bone disease: pathophysiology of osteoblast inhibition","volume":"108","author":"Giuliani","year":"2006","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2010.11.006_bib10","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1182\/blood-2007-03-067710","article-title":"Myeloma bone disease and proteasome inhibition therapies","volume":"110","author":"Terpos","year":"2007","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2010.11.006_bib11","first-page":"4","article-title":"Multiple myeloma","author":"Collins","year":"2004","journal-title":"Cancer Imaging"},{"key":"10.1053\/j.seminhematol.2010.11.006_bib12","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1148\/radiol.2341040731","article-title":"Skeletal abnormalities in multiple myeloma","volume":"234","author":"Mulligan","year":"2005","journal-title":"Radiology"},{"key":"10.1053\/j.seminhematol.2010.11.006_bib13","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.2214\/ajr.178.6.1781429","article-title":"Multidetector CT of the spine in multiple myeloma: comparison with MR imaging and radiography","volume":"178","author":"Mahnken","year":"2002","journal-title":"AJR Am J Roentgenol"},{"key":"10.1053\/j.seminhematol.2010.11.006_bib14","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ejrad.2004.04.015","article-title":"Whole-body low-dose multidetector row-CT in the diagnosis of multiple myeloma: an alternative to conventional radiography","volume":"54","author":"Horger","year":"2005","journal-title":"Eur J Radiol"},{"key":"10.1053\/j.seminhematol.2010.11.006_bib15","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/01.rct.0000237820.41549.c9","article-title":"Efficacy of multidetector row computed tomography of the spine in patients with multiple myeloma: comparison with magnetic resonance imaging and fluorodeoxyglucose-positron emission tomography","volume":"31","author":"Hur","year":"2007","journal-title":"J Comput Assist Tomogr"},{"key":"10.1053\/j.seminhematol.2010.11.006_bib16","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.rcl.2008.05.002","article-title":"Oncohaematologic disorders affecting the skeleton in the elderly","volume":"46","author":"Baur-Melnyk","year":"2008","journal-title":"Radiol Clin North Am"},{"key":"10.1053\/j.seminhematol.2010.11.006_bib17","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.2214\/ajr.178.6.1781429","article-title":"Multidetector CT of the spine in multiple myeloma: comparison with MR imaging and radiography","volume":"178","author":"Mahnken","year":"2002","journal-title":"AJR Am J Roentgenol"},{"key":"10.1053\/j.seminhematol.2010.11.006_bib18","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ejrad.2004.04.015","article-title":"Whole-body low-dose multidetector row-CT in the diagnosis of multiple myeloma: an alternative to conventional radiography","volume":"54","author":"Horger","year":"2005","journal-title":"Eur J Radiol"},{"key":"10.1053\/j.seminhematol.2010.11.006_bib19","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1007\/s00330-005-0055-7","article-title":"Whole-body MRI in the detection of bone marrow infiltration in patients with plasma cell neoplasms in comparison to the radiological skeletal survey","volume":"16","author":"Ghanem","year":"2006","journal-title":"Eur Radiol"},{"key":"10.1053\/j.seminhematol.2010.11.006_bib20","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2214\/ajr.162.1.8273669","article-title":"MR imaging of bone marrow lesions: relative conspicuousness on T1-weighted, fat-suppressed T2-weighted, and STIR images","volume":"162","author":"Mirowitz","year":"1994","journal-title":"AJR Am J Roentgenol"},{"key":"10.1053\/j.seminhematol.2010.11.006_bib21","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1007\/s00330-005-0055-7","article-title":"Whole-body MRI in the detection of bone marrow infiltration in patients with plasma cell neoplasms in comparison to the radiological skeletal survey","volume":"16","author":"Ghanem","year":"2006","journal-title":"Eur Radiol"},{"key":"10.1053\/j.seminhematol.2010.11.006_bib22","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.2214\/AJR.07.2635","article-title":"Whole-body MRI versus whole-body MDCT for staging of multiple myeloma","volume":"190","author":"Baur-Melnyk","year":"2008","journal-title":"AJR Am J Roentgenol"},{"key":"10.1053\/j.seminhematol.2010.11.006_bib23","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1200\/JCO.2006.08.5803","article-title":"Magnetic resonance imaging in multiple myeloma: diagnostic and clinical implications","volume":"25","author":"Walker","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminhematol.2010.11.006_bib24","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1055\/s-2007-1015689","article-title":"Infiltration patterns of plasmacytomas in magnetic resonance tomography [in German]","volume":"164","author":"Baur","year":"1996","journal-title":"Rofo"},{"key":"10.1053\/j.seminhematol.2010.11.006_bib25","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1002\/cncr.10818","article-title":"Magnetic resonance imaging as a supplement for the clinical staging system of Durie and Salmon?","volume":"95","author":"Baur","year":"2002","journal-title":"Cancer"},{"key":"10.1053\/j.seminhematol.2010.11.006_bib26","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1365-2141.2006.06217.x","article-title":"Lumbar bone mineral density as the major factor determining increased prevalence of vertebral fractures in monoclonal gammopathy of undetermined significance","volume":"134","author":"Pepe","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2010.11.006_bib27","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1097\/00007632-199711010-00017","article-title":"Magnetic resonance appearance of monoclonal gammopathies of unknown significance and multiple myeloma","volume":"22","author":"Bellaiche","year":"1997","journal-title":"Spine"},{"key":"10.1053\/j.seminhematol.2010.11.006_bib28","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1148\/radiology.202.1.8988218","article-title":"Nonmyelomatous monoclonal gammopathy: correlation of bone marrow MR images with laboratory findings and spontaneous clinical outcome","volume":"202","author":"Vande Berg","year":"1997","journal-title":"Radiology"},{"key":"10.1053\/j.seminhematol.2010.11.006_bib29","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1200\/JCO.1995.13.1.251","article-title":"Prognostic significance of magnetic resonance imaging in patients with asymptomatic multiple myeloma","volume":"13","author":"Moulopoulos","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminhematol.2010.11.006_bib30","first-page":"687a","article-title":"Abnormal MRI of spine is the dominant risk factor for early progression of asymptomatic multiple myeloma [abstract]","volume":"102","author":"Wang","year":"2003","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2010.11.006_bib31","doi-asserted-by":"crossref","first-page":"3955","DOI":"10.1200\/JCO.2003.08.092","volume":"21","author":"Morgan","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminhematol.2010.11.006_bib32","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1158\/1078-0432.CCR-06-0061","article-title":"Lumbar bone marrow microcirculation measurements from dynamic contrast-enhanced magnetic resonance imaging is a predictor of event-free survival in progressive multiple myeloma","volume":"13","author":"Hillengass","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1053\/j.seminhematol.2010.11.006_bib33","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0093-7754(01)90025-9","article-title":"Increased bone marrow microvessel density in newly diagnosed multiple myeloma carries a poor prognosis","volume":"28","author":"Munshi","year":"2001","journal-title":"Semin Oncol"},{"key":"10.1053\/j.seminhematol.2010.11.006_bib34","doi-asserted-by":"crossref","first-page":"3118","DOI":"10.1158\/1078-0432.CCR-08-2310","article-title":"Dynamic contrast-enhanced magnetic resonance imaging identifies a subgroup of patients with asymptomatic monoclonal plasma cell disease and pathologic microcirculation","volume":"15","author":"Hillengass","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1053\/j.seminhematol.2010.11.006_bib35","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1148\/radiology.134.3.7355226","article-title":"Comparison of bone scintigraphy and radiography in multiple myeloma","volume":"134","author":"Woolfenden","year":"1980","journal-title":"Radiology"},{"key":"10.1053\/j.seminhematol.2010.11.006_bib36","first-page":"1646","article-title":"Effect of mitochondrial and plasma membrane potentials on accumulation of hexakis (2-methoxyisobutylisonitrile) technetium(I) in cultured mouse fibroblasts","volume":"31","author":"Chiu","year":"1990","journal-title":"J Nucl Med"},{"key":"10.1053\/j.seminhematol.2010.11.006_bib37","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/j.1365-2141.2006.06489.x","article-title":"Technetium-99m sestamibi scintigraphy is sensitive and specific for the staging and the follow-up of patients with multiple myeloma: a multicentre study on 397 scans","volume":"136","author":"Mele","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2010.11.006_bib38","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1046\/j.1365-2257.2002.00201.x","article-title":"Correlation between the uptake of Tc99m-sestamibi and prognostic factors in patients with multiple myeloma","volume":"24","author":"Alexandrakis","year":"2002","journal-title":"Clin Lab Hematol"},{"key":"10.1053\/j.seminhematol.2010.11.006_bib39","first-page":"355","article-title":"Staging and therapy monitoring of multiple myeloma by 99mTc-sestamibi scintigraphy: a five year single center experience","volume":"24","author":"Villa","year":"2005","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1053\/j.seminhematol.2010.11.006_bib40","first-page":"1457","article-title":"Whole-body (18)F-FDG PET identifies high-risk myeloma","volume":"43","author":"Durie","year":"2002","journal-title":"J Nucl Med"},{"key":"10.1053\/j.seminhematol.2010.11.006_bib41","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1016\/j.ejca.2005.11.037","article-title":"The role of anatomic and functional staging in myeloma: description of Durie\/Salmon plus staging system","volume":"42","author":"Durie","year":"2006","journal-title":"Eur J Cancer"},{"key":"10.1053\/j.seminhematol.2010.11.006_bib42","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s00259-001-0711-3","article-title":"Initial results in the assessment of multiple myeloma using 18F-FDG PET","volume":"29","author":"Schirrmeister","year":"2002","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.seminhematol.2010.11.006_bib43","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.2214\/ajr.184.4.01841199","article-title":"Value of FDG PET in the assessment of patients with multiple myeloma","volume":"184","author":"Bredella","year":"2005","journal-title":"AJR Am J Roentgenol"},{"key":"10.1053\/j.seminhematol.2010.11.006_bib44","doi-asserted-by":"crossref","first-page":"980","DOI":"10.2214\/AJR.08.1633","article-title":"Whole-body MRI versus PET in assessment of multiple myeloma disease activity","volume":"192","author":"Shortt","year":"2009","journal-title":"AJR Am J Roentgenol"},{"key":"10.1053\/j.seminhematol.2010.11.006_bib45","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2967\/jnumed.107.045641","article-title":"18F-FDG PET\/CT, 99mTc-MIBI, and MRI in evaluation of patients with multiple myeloma","volume":"49","author":"Fonti","year":"2008","journal-title":"J Nucl Med"},{"key":"10.1053\/j.seminhematol.2010.11.006_bib46","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0001-2998(72)80005-9","article-title":"18F-fluoride for bone imaging","volume":"2","author":"Blau","year":"1972","journal-title":"Semin Nucl Med"},{"key":"10.1053\/j.seminhematol.2010.11.006_bib47","first-page":"1800","article-title":"Prospective evaluation of the clinical value of planar bone scans, SPECT, and (18)F-labeled NaF PET in newly diagnosed lung cancer","volume":"42","author":"Schirrmeister","year":"2001","journal-title":"J Nucl Med"},{"key":"10.1053\/j.seminhematol.2010.11.006_bib48","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1053\/snuc.2001.18746","article-title":"The role of positron emission tomography in skeletal disease","volume":"31","author":"Cook","year":"2001","journal-title":"Semin Nucl Med"},{"key":"10.1053\/j.seminhematol.2010.11.006_bib49","first-page":"287","article-title":"The detection of bone metastases in patients with high- risk prostate cancer: 99mTc-MDP planar bone scintigraphy, single- and multi-field-of-view SPECT, 18F-fluoride PET, and 18F-fluoride PET\/CT","volume":"47","author":"Even-Sapir","year":"2006","journal-title":"J Nucl Med"},{"key":"10.1053\/j.seminhematol.2010.11.006_bib50","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1053\/snuc.2001.18742","article-title":"Quantitative studies of bone with the use of 18F-fluoride and 99mTc-methylene diphosphonate","volume":"31","author":"Blake","year":"2001","journal-title":"Semin Nucl Med"},{"key":"10.1053\/j.seminhematol.2010.11.006_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.acra.2010.08.002","article-title":"Response assessment in patients with multiple myeloma during antiangiogenic therapy using arterial spin labeling and diffusion-weighted imaging a feasibility study","author":"Fenchel","year":"2010","journal-title":"Acad Radiol"},{"key":"10.1053\/j.seminhematol.2010.11.006_bib52","first-page":"1592","article-title":"18F-FLT PET in hematologic disorders: a novel technique to analyze the bone marrow compartment","volume":"47","author":"Agool","year":"2006","journal-title":"J Nucl Med"},{"key":"10.1053\/j.seminhematol.2010.11.006_bib53","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1148\/radiol.2422051980","article-title":"Multiple myeloma: molecular imaging with 11C-methionine PET\/CT: initial experience","volume":"242","author":"Dankerl","year":"2007","journal-title":"Radiology"},{"key":"10.1053\/j.seminhematol.2010.11.006_bib54","doi-asserted-by":"crossref","first-page":"879","DOI":"10.2967\/jnumed.107.049452","article-title":"Phase I trial of the positron-emitting Arg-Gly-Asp (RGD) peptide radioligand 18F-AH111585 in breast cancer patients","volume":"49","author":"Kenny","year":"2008","journal-title":"J Nucl Med"},{"key":"10.1053\/j.seminhematol.2010.11.006_bib55","doi-asserted-by":"crossref","first-page":"116","DOI":"10.2967\/jnumed.108.056077","article-title":"Use of a novel Arg-Gly-Asp radioligand, 18F-AH111585, to determine changes in tumor vascularity after antitumor therapy","volume":"50","author":"Morrison","year":"2009","journal-title":"J Nucl Med"},{"key":"10.1053\/j.seminhematol.2010.11.006_bib56","doi-asserted-by":"crossref","first-page":"8452","DOI":"10.1074\/jbc.M412750200","article-title":"Modulation of the actin cytoskeleton via gelsolin regulates vacuolar H+-ATPase recycling","volume":"280","author":"Beaulieu","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1053\/j.seminhematol.2010.11.006_bib57","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/1477-7819-5-68","article-title":"11C-choline vs. 18F-FDG PET\/CT in assessing bone involvement in patients with multiple myeloma","volume":"5","author":"Nanni","year":"2007","journal-title":"World J Surg Oncol"},{"key":"10.1053\/j.seminhematol.2010.11.006_bib58","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s12185-010-0595-8","article-title":"11C-methionine PET\/CT for multiple myeloma","volume":"91","author":"Nishizawa","year":"2010","journal-title":"Int J Hematol"}],"container-title":["Seminars in Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196310001095?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196310001095?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T06:21:43Z","timestamp":1758522103000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0037196310001095"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["S0037196310001095"],"URL":"https:\/\/doi.org\/10.1053\/j.seminhematol.2010.11.006","relation":{},"ISSN":["0037-1963"],"issn-type":[{"value":"0037-1963","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular Imaging in Myeloma Precursor Disease","name":"articletitle","label":"Article Title"},{"value":"Seminars in Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.seminhematol.2010.11.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}